Mesa Laboratories Inc (MLAB)
Pretax margin
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 5,961 | -269,832 | -265,669 | -270,806 | -275,648 | -593 | -623 | 4,086 | -389 | -158 | -4,415 | -3,256 | 3,574 | 8,512 | 5,126 | 2,967 | 1,931 | -3,349 | -2,825 | -1,545 |
| Revenue (ttm) | US$ in thousands | 240,978 | 237,747 | 228,380 | 223,712 | 216,187 | 212,874 | 213,688 | 219,272 | 219,080 | 222,368 | 222,777 | 199,868 | 184,335 | 163,420 | 142,896 | 138,916 | 133,937 | 130,181 | 127,664 | 121,340 |
| Pretax margin | 2.47% | -113.50% | -116.33% | -121.05% | -127.50% | -0.28% | -0.29% | 1.86% | -0.18% | -0.07% | -1.98% | -1.63% | 1.94% | 5.21% | 3.59% | 2.14% | 1.44% | -2.57% | -2.21% | -1.27% |
March 31, 2025 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $5,961K ÷ $240,978K
= 2.47%
The pretax margin of Mesa Laboratories Inc has shown fluctuating trends over the past few years. It started with negative margins in the range of -1.27% to -2.57% in the second half of 2020. However, the company managed to turn this around with positive pretax margins of 1.44% to 5.21% through 2021 and the first half of 2022.
In the latter part of 2022 and into 2023, Mesa Laboratories faced challenges as the pretax margins dipped again, hovering around -1.98% to 1.86%. The company struggled to maintain profitability, with negative margins persisting from late 2023 to mid-2024, reaching alarming levels of -127.50% to -113.50%.
The most recent data shows an improvement in the pretax margin for Mesa Laboratories, rebounding to 2.47% as of March 31, 2025. This indicates that the company has managed to address its profitability concerns and is moving in a positive direction again. Overall, the pretax margin performance of Mesa Laboratories reflects a mix of challenges and recoveries, highlighting the importance of sustained financial management and strategic decision-making to ensure long-term profitability.
Peer comparison
Mar 31, 2025